FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160163906> ?p ?o ?g. }

• W2160163906 endingPage "2083" @default.
• W2160163906 startingPage "2071" @default.
• W2160163906 abstract "Abstract Purpose: Malignant mesothelioma is a devastating disease with a need for new treatment strategies. In the present study, we showed the importance of extracellular signal–regulated kinase 5 (ERK5) in malignant mesothelioma tumor growth and treatment. Experimental Design: ERK5 as a target for malignant mesothelioma therapy was verified using mesothelial and mesothelioma cell lines as well as by xenograft severe combined immunodeficient (SCID) mouse models. Results: We first showed that crocidolite asbestos activated ERK5 in LP9 cells and mesothelioma cell lines exhibit constitutive activation of ERK5. Addition of doxorubicin resulted in further activation of ERK5 in malignant mesothelioma cells. ERK5 silencing increased doxorubicin-induced cell death and doxorubicin retention in malignant mesothelioma cells. In addition, shERK5 malignant mesothelioma lines exhibited both attenuated colony formation on soft agar and invasion of malignant mesothelioma cells in vitro that could be related to modulation of gene expression linked to cell proliferation, apoptosis, migration/invasion, and drug resistance as shown by microarray analysis. Most importantly, injection of shERK5 malignant mesothelioma cell lines into SCID mice showed significant reduction in tumor growth using both subcutaneous and intraperitoneal models. Assessment of selected human cytokine profiles in peritoneal lavage fluid from intraperitoneal shERK5 and control tumor-bearing mice showed that ERK5 was critical in regulation of various proinflammatory (RANTES/CCL5, MCP-1) and angiogenesis-related (interleukin-8, VEGF) cytokines. Finally, use of doxorubicin and cisplatin in combination with ERK5 inhibition showed further reduction in tumor weight and volume in the intraperitoneal model of tumor growth. Conclusion: ERK5 inhibition in combination with chemotherapeutic drugs is a beneficial strategy for combination therapy in patients with malignant mesothelioma. Clin Cancer Res; 19(8); 2071–83. ©2013 AACR." @default.
• W2160163906 created "2016-06-24" @default.
• W2160163906 creator A5012650103 @default.
• W2160163906 creator A5019739326 @default.
• W2160163906 creator A5040898114 @default.
• W2160163906 creator A5060700887 @default.
• W2160163906 creator A5064450502 @default.
• W2160163906 creator A5070542630 @default.
• W2160163906 creator A5071832113 @default.
• W2160163906 creator A5078956487 @default.
• W2160163906 creator A5089331359 @default.
• W2160163906 creator A5089386096 @default.
• W2160163906 date "2013-04-15" @default.
• W2160163906 modified "2023-10-18" @default.
• W2160163906 title "Extracellular Signal–Regulated Kinase 5: A Potential Therapeutic Target for Malignant Mesotheliomas" @default.
• W2160163906 cites W1256324905 @default.
• W2160163906 cites W1515678882 @default.
• W2160163906 cites W1774418672 @default.
• W2160163906 cites W1941604278 @default.
• W2160163906 cites W1968853726 @default.
• W2160163906 cites W1974347350 @default.
• W2160163906 cites W1988976835 @default.
• W2160163906 cites W1993903799 @default.
• W2160163906 cites W2004402774 @default.
• W2160163906 cites W2010325864 @default.
• W2160163906 cites W2011952213 @default.
• W2160163906 cites W2018259909 @default.
• W2160163906 cites W2021736277 @default.
• W2160163906 cites W2027929872 @default.
• W2160163906 cites W2044167464 @default.
• W2160163906 cites W2050795771 @default.
• W2160163906 cites W2053841000 @default.
• W2160163906 cites W2056241456 @default.
• W2160163906 cites W2064942669 @default.
• W2160163906 cites W2066717330 @default.
• W2160163906 cites W2070717171 @default.
• W2160163906 cites W2074227594 @default.
• W2160163906 cites W2090282518 @default.
• W2160163906 cites W2091475315 @default.
• W2160163906 cites W2094794384 @default.
• W2160163906 cites W2095663005 @default.
• W2160163906 cites W2096763507 @default.
• W2160163906 cites W2101221827 @default.
• W2160163906 cites W2102987835 @default.
• W2160163906 cites W2103823463 @default.
• W2160163906 cites W2115803781 @default.
• W2160163906 cites W2122411707 @default.
• W2160163906 cites W2125169413 @default.
• W2160163906 cites W2127971712 @default.
• W2160163906 cites W2128487347 @default.
• W2160163906 cites W2131186576 @default.
• W2160163906 cites W2136032785 @default.
• W2160163906 cites W2136669302 @default.
• W2160163906 cites W2148062526 @default.
• W2160163906 cites W2154590917 @default.
• W2160163906 cites W4231082968 @default.
• W2160163906 doi "https://doi.org/10.1158/1078-0432.ccr-12-3202" @default.
• W2160163906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3630261" @default.
• W2160163906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23446998" @default.
• W2160163906 hasPublicationYear "2013" @default.
• W2160163906 type Work @default.
• W2160163906 sameAs 2160163906 @default.
• W2160163906 citedByCount "36" @default.
• W2160163906 countsByYear W21601639062013 @default.
• W2160163906 countsByYear W21601639062014 @default.
• W2160163906 countsByYear W21601639062015 @default.
• W2160163906 countsByYear W21601639062016 @default.
• W2160163906 countsByYear W21601639062017 @default.
• W2160163906 countsByYear W21601639062018 @default.
• W2160163906 countsByYear W21601639062019 @default.
• W2160163906 countsByYear W21601639062020 @default.
• W2160163906 countsByYear W21601639062021 @default.
• W2160163906 countsByYear W21601639062022 @default.
• W2160163906 countsByYear W21601639062023 @default.
• W2160163906 crossrefType "journal-article" @default.
• W2160163906 hasAuthorship W2160163906A5012650103 @default.
• W2160163906 hasAuthorship W2160163906A5019739326 @default.
• W2160163906 hasAuthorship W2160163906A5040898114 @default.
• W2160163906 hasAuthorship W2160163906A5060700887 @default.
• W2160163906 hasAuthorship W2160163906A5064450502 @default.
• W2160163906 hasAuthorship W2160163906A5070542630 @default.
• W2160163906 hasAuthorship W2160163906A5071832113 @default.
• W2160163906 hasAuthorship W2160163906A5078956487 @default.
• W2160163906 hasAuthorship W2160163906A5089331359 @default.
• W2160163906 hasAuthorship W2160163906A5089386096 @default.
• W2160163906 hasBestOaLocation W21601639061 @default.
• W2160163906 hasConcept C126322002 @default.
• W2160163906 hasConcept C142724271 @default.
• W2160163906 hasConcept C2776694085 @default.
• W2160163906 hasConcept C2777407522 @default.
• W2160163906 hasConcept C2781303535 @default.
• W2160163906 hasConcept C502942594 @default.
• W2160163906 hasConcept C71924100 @default.
• W2160163906 hasConceptScore W2160163906C126322002 @default.
• W2160163906 hasConceptScore W2160163906C142724271 @default.
• W2160163906 hasConceptScore W2160163906C2776694085 @default.
• W2160163906 hasConceptScore W2160163906C2777407522 @default.
• W2160163906 hasConceptScore W2160163906C2781303535 @default.

• next